JP2022544704A5 - - Google Patents
Info
- Publication number
- JP2022544704A5 JP2022544704A5 JP2022511223A JP2022511223A JP2022544704A5 JP 2022544704 A5 JP2022544704 A5 JP 2022544704A5 JP 2022511223 A JP2022511223 A JP 2022511223A JP 2022511223 A JP2022511223 A JP 2022511223A JP 2022544704 A5 JP2022544704 A5 JP 2022544704A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- tcr
- recombinant hcmv
- mhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025093613A JP2025131719A (ja) | 2019-08-20 | 2025-06-04 | ヒトサイトメガロウイルスのｕｌ１８によるｔ細胞応答の調節 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962889310P | 2019-08-20 | 2019-08-20 | |
| US62/889,310 | 2019-08-20 | ||
| PCT/US2020/047050 WO2021034964A1 (en) | 2019-08-20 | 2020-08-19 | Modulation of t cell responses by ul18 of human cytomegalovirus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025093613A Division JP2025131719A (ja) | 2019-08-20 | 2025-06-04 | ヒトサイトメガロウイルスのｕｌ１８によるｔ細胞応答の調節 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022544704A JP2022544704A (ja) | 2022-10-20 |
| JP2022544704A5 true JP2022544704A5 (enExample) | 2023-07-20 |
| JP7693651B2 JP7693651B2 (ja) | 2025-06-17 |
Family
ID=74660048
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022511223A Active JP7693651B2 (ja) | 2019-08-20 | 2020-08-19 | ヒトサイトメガロウイルスのｕｌ１８によるｔ細胞応答の調節 |
| JP2025093613A Pending JP2025131719A (ja) | 2019-08-20 | 2025-06-04 | ヒトサイトメガロウイルスのｕｌ１８によるｔ細胞応答の調節 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025093613A Pending JP2025131719A (ja) | 2019-08-20 | 2025-06-04 | ヒトサイトメガロウイルスのｕｌ１８によるｔ細胞応答の調節 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220307054A1 (enExample) |
| EP (1) | EP4017985A4 (enExample) |
| JP (2) | JP7693651B2 (enExample) |
| KR (1) | KR20220047619A (enExample) |
| CN (1) | CN114402080B (enExample) |
| AU (1) | AU2020334061B2 (enExample) |
| BR (1) | BR112022003159A2 (enExample) |
| CA (1) | CA3148642A1 (enExample) |
| CL (1) | CL2022000398A1 (enExample) |
| CO (1) | CO2022002922A2 (enExample) |
| CR (1) | CR20220093A (enExample) |
| DO (1) | DOP2022000041A (enExample) |
| EC (1) | ECSP22013145A (enExample) |
| IL (1) | IL290748A (enExample) |
| MX (1) | MX2022002154A (enExample) |
| MY (1) | MY210519A (enExample) |
| PE (1) | PE20220648A1 (enExample) |
| PH (1) | PH12022550439A1 (enExample) |
| WO (1) | WO2021034964A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240384296A1 (en) * | 2021-08-31 | 2024-11-21 | Vir Biotechnology, Inc. | Recombinant hcmv vectors and uses thereof |
| WO2024059635A2 (en) * | 2022-09-13 | 2024-03-21 | Oregon Health And Science University | Universal t cell-based, cmv-vectored vaccine for influenza |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1410314A (en) | 1920-11-04 | 1922-03-21 | Edgar B Hyatt | Garage-door control |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US20020069244A1 (en) | 1999-11-24 | 2002-06-06 | John Blair | Message delivery system billing method and apparatus |
| CA2437201C (en) * | 2001-02-02 | 2008-11-18 | Chemocentryx, Inc. | Methods and compositions useful for stimulating an immune response |
| EP2074747B1 (en) | 2006-09-28 | 2015-08-05 | PacketFront Network Products AB | Method for automatically providing a customer equipment with the correct service |
| DE112013006773T5 (de) | 2013-03-06 | 2015-12-10 | SiEVA | Vorrichtung für high-side Transistor-Brückentreiber |
| US10752902B2 (en) * | 2014-09-23 | 2020-08-25 | Board Of Trustees Of Michigan State University | Compositions comprising fusion proteins useful for modulating an immune response |
| EA201791806A1 (ru) * | 2015-02-10 | 2017-12-29 | Орегон Хелс Энд Сайенс Юниверсити | Способы и композиции, полезные при генерировании неканонических cd8+ т-клеточных ответов |
| US10688164B2 (en) | 2015-11-20 | 2020-06-23 | Oregon Health & Science University | CMV vectors comprising microRNA recognition elements |
| AU2017280065B2 (en) * | 2016-06-22 | 2021-07-01 | International Aids Vaccine Initiative, Inc. | Recombinant cytomegalovirus vectors as vaccines for tuberculosis |
| WO2018075591A1 (en) | 2016-10-18 | 2018-04-26 | Oregon Health & Science University | Cytomegalovirus vectors eliciting t cells restricted by major histocompatibility complex e molecules |
-
2020
- 2020-08-19 CA CA3148642A patent/CA3148642A1/en active Pending
- 2020-08-19 MY MYPI2022000951A patent/MY210519A/en unknown
- 2020-08-19 KR KR1020227008642A patent/KR20220047619A/ko active Pending
- 2020-08-19 WO PCT/US2020/047050 patent/WO2021034964A1/en not_active Ceased
- 2020-08-19 MX MX2022002154A patent/MX2022002154A/es unknown
- 2020-08-19 BR BR112022003159A patent/BR112022003159A2/pt unknown
- 2020-08-19 JP JP2022511223A patent/JP7693651B2/ja active Active
- 2020-08-19 AU AU2020334061A patent/AU2020334061B2/en active Active
- 2020-08-19 PH PH1/2022/550439A patent/PH12022550439A1/en unknown
- 2020-08-19 CN CN202080064753.2A patent/CN114402080B/zh active Active
- 2020-08-19 US US17/636,506 patent/US20220307054A1/en active Pending
- 2020-08-19 EP EP20855077.2A patent/EP4017985A4/en active Pending
- 2020-08-19 PE PE2022000281A patent/PE20220648A1/es unknown
- 2020-08-19 CR CR20220093A patent/CR20220093A/es unknown
-
2022
- 2022-02-18 EC ECSENADI202213145A patent/ECSP22013145A/es unknown
- 2022-02-18 CL CL2022000398A patent/CL2022000398A1/es unknown
- 2022-02-18 DO DO2022000041A patent/DOP2022000041A/es unknown
- 2022-02-20 IL IL290748A patent/IL290748A/en unknown
- 2022-03-14 CO CONC2022/0002922A patent/CO2022002922A2/es unknown
-
2025
- 2025-06-04 JP JP2025093613A patent/JP2025131719A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019531745A5 (enExample) | ||
| JP2019502371A5 (enExample) | ||
| Xiao et al. | CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy | |
| US11305015B2 (en) | Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules | |
| JP7133468B2 (ja) | マイクロｒｎａ認識エレメントを含むｃｍｖベクター | |
| JP2020188777A (ja) | ヒト由来インターロイキン６のｓｉＲＮＡ、組換え発現ＣＡＲ−Ｔベクターおよびその構築方法と使用 | |
| JP2019535303A (ja) | Ｐｄｌ１がブロッキングされた免疫逃避を抑制するためのｃａｒ−ｔ遺伝子組換えベクターおよびその構築方法と使用 | |
| EP3993826B1 (en) | Novel cancer antigens and methods | |
| US20230068154A1 (en) | Multivirus-specific t cell immunotherapy | |
| JP2019535302A (ja) | Ｉｌ６ｒがブロッキングされたｃｒｓを緩和するためのｃａｒ−ｔ遺伝子組換えベクターおよびその構築方法と使用 | |
| Li et al. | mRNA vaccines: current applications and future directions | |
| JP2025157424A (ja) | 腫瘍関連抗原特異的ｔ細胞応答 | |
| JP2025131719A (ja) | ヒトサイトメガロウイルスのｕｌ１８によるｔ細胞応答の調節 | |
| JP2024534189A5 (enExample) | ||
| Mossoba et al. | Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials | |
| CN102787119B (zh) | 治疗和/或预防病毒感染的产品及方法 | |
| CN110878126A (zh) | Tcr样嵌合抗原受体及其应用 | |
| JP2023507142A5 (enExample) | ||
| Zhang et al. | Molecular Screening and Neoantigen Cloning-Fundamental of Adoptive T-cell Immunotherapy | |
| NZ785288B2 (en) | Modulation of t cell responses by ul18 of human cytomegalovirus | |
| HK40073534A (en) | Modulation of t cell responses by ul18 of human cytomegalovirus | |
| HK40073534B (en) | Modulation of t cell responses by ul18 of human cytomegalovirus | |
| Hu et al. | Targeting solid tumors with TCR-T cells: mechanisms, progress, and challenges | |
| CN121554596A (zh) | 一类链接包含apc在内的表达cd40的细胞和靶点特异性t细胞的融合蛋白及其运用 | |
| HIV | 663. In Vitro Characterization of the Anti-Viral Activity of TT-034, a RNAi-Therapeutic Against the Hepatitis C Virus |